Back to Journals

Pharmacogenomics and Personalized Medicine

Aims and Scope

Editor-in-Chief: Dr Martin H Bluth

Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to: 

  • Genomic and proteomic profiling
  • Genetics and drug metabolism
  • Targeted drug identification and discovery
  • Optimizing drug selection & dosage based on patient's genetic profile
  • Drug related morbidity & mortality intervention
  • Advanced disease screening and targeted therapeutic intervention
  • Genetic based vaccine development
  • Patient satisfaction and preference
  • Health economic evaluations
  • Practical and organizational issues in the development and implementation of personalized medicine programs 

The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews and evaluations, guidelines, policy papers, expert opinion and commentary, case reports and extended reports.

Pharmacogenomics and Personalized Medicine will no longer consider meta-analyses for publication.